Q2 T2Bmeet @ NY/NJ 2025
***If you're a T2B member and do not receive your confirmation within 1 business day of RSVPing (above), check your email spam folder. The automated Luma email includes the cal invite.***
T2Bmeet pricing:
Complimentary for T2B Pro and Student community members (log into your T2B account and access your promo code here)
$50 for Basic members
If you're not part of Ticket to Biotech, confirm you're eligible, and join before registering for this event:
T2B Intake Form
Hosted by Mission North at their Manhattan office, this come-and-go networking event, including a panel discussion, is open to all biopharma communicators in the T2B community. Complimentary refreshments will be provided. Come mix and mingle with fellow comms pros!
Program
4:30-5:15 p.m.: Registration and networking
5:15-5:45 p.m.: Panel discussion
5:45-6 p.m.: Q&A
6-7 p.m.: Networking reception
Panel Discussion Overview
Uncharted waters: Biopharma communications in an era of uncertainty
Biopharma companies today are grappling with cautious investors, political and regulatory shifts, fragmented media, and the rapid emergence of AI. At Ticket to Biotech's quarterly NY meetup, hosted by Mission North, we’re bringing together voices from investing, PR, media, government, and in-house comms for a frank, wide-ranging discussion on how to adapt and lead in this moment. We'll explore:
Communicating value as investors shift focus toward later-stage companies
Breaking through in a shrinking, high-pressure media environment
Elevating executive voices through owned and controlled content
Navigating the digital shift: AI tools, new platforms, and the rise of influencers
Adapting to sudden changes in government funding and regulation
Moderator:
Tyler Perry, Co-CEO, Mission North
Panelists:
Susan Hager, Chief Marketing Officer, Andreessen Horowitz Bio + Health
Ryan Kelly, Chief Communications Officer, Recursion
Anjalee Khemlani, Senior Health Reporter, Yahoo! Finance
Loren Dealy Mahler, Communications Director, National Security Commission on Emerging Biotechnology
About Our Guest Speakers
Sue Hager is an operating partner and the Chief Marketing Officer on the Bio + Health investing team. She oversees marketing, branding, and health policy for the fund.
Prior to joining Andreessen Horowitz, she was chief investor relations and communications officer for Section 32 venture capital. Sue also served as chief communications officer and head of health policy and advocacy for life sciences companies including EQRx (Nasdaq: EQRx) and Foundation Medicine (acquired by Roche) where, among other initiatives in her six-year tenure, she led the company’s efforts to secure the first broad Medicare Coverage Decision for comprehensive genomic profiling in oncology. Previously she served in similar roles at companies including Bayer Healthcare, Myriant Corporation (acquired by PTT Global Chemical), Targanta (acquired by The Medicines Company) and Coley Pharmaceutical (acquired by Pfizer).
She holds a BS with honors in biology and earned her MBA from Northeastern University in Boston, MA. Sue currently serves on the Board of Directors for MassBio and the Emily Whitehead Foundation. Sue grew up in Rhode Island and returned there recently, where she enjoys boating, surfing, cycling, and hiking with her husband and their dogs.
Ryan Kelly is Chief Communications Officer at Recursion, the leading TechBio with a mission to fundamentally change the way drugs are discovered. Since joining Recursion three years ago, he has led the company’s internal and external communications through key pipeline updates, partnership milestones with NVIDIA, Bayer, Roche & Genentech, and its combination with two private companies and with Exscientia – the largest M&A deal inTechBio. Internally at Recursion, Ryan was the executive sponsor for the launch of the company’s first ERG program, which has evolved into a Pride ERG, a women’s ERG and a people of color ERG.
Ryan has deep expertise driving communications that share the impact of cutting-edge technologies, having previously served as Vice President of Marketing and Communications, Hyperloop, at the Virgin Group. Earlier in his career, he held in-house and agency roles in digital advertising and creative, including as a partner at GW New York and Catch24 serving clients like Bosch, Salesforce, Oracle, PwC, and Lufthansa, and on the digital team at The New York Times.
Ryan served as a General Assembly instructor across digital strategy, data, and analytics for nearly a decade, and advises multiple startups looking for marketing and communications support. He is currently a board member for both Ballet West and Equality Utah.
Anjalee Khemlani is an award-winning journalist and senior reporter at Yahoo! Finance. Her role includes live reports and articles covering all things health care including digital health, insurance, health services and life sciences. She leads daily coverage of GLP-1s, PBMs and most recently tariffs and drug pricing. Prior to Yahoo! Finance, Khemlani worked for a variety of regional and international news outlets covering breaking news, healthcare, business, DEI and politics.
Loren Dealy Mahler is the Communications Director for the National Security Commission on Biotechnology. For over two decades she has worked at the intersection of national security and emerging technology, in both government and private sector roles. Loren is a communications and public affairs strategist with extensive experience navigating the intersection between government and industry to advance organizational objectives through more effective communications and external engagement strategies.
After a decade in Washington DC, where she worked at the White House, Department of Defense, and on Capitol Hill, Loren moved to the greater New York area, where she has advised established corporations and growth-oriented start-ups from a variety of industries. Her extensive experience allows her to seamlessly navigate the complexities of growing and protecting ideas and organizations in today's volatile climate.
She is a fellow with the Truman National Security Project and the National Security Institute at GMU, as well as a member of Chief.
Tyler Perry has more than 20 years of experience providing strategic counsel to startups and larger brands, and still gets irrationally excited telling stories about the companies that are changing how we live, work and play. She co-leads Mission North as well as the company’s product strategy and integration work. A generalist at heart, Tyler oversees the company’s Fintech, Future of Work and Life Sciences practices, and has worked with a wide range of brands, past and present, including Betterment, Ginkgo Bioworks, L’Oreal, Braintree, Venmo and Flatiron School.
In her previous life, Tyler worked with emerging fashion, lifestyle and retail companies on building brands and driving consumer acquisition. She started her PR career during the dotcom heyday and enjoyed every ridiculous minute of it, leaving only for a few years to moonlight as a hedge fund analyst.
Tyler is the ringleader of the Williams College mafia at Mission North. Her pug Tots is a regular fixture in the New York office, as are the trials and tribulations of her two very spirited boys.
About Our Host, Mission North
Awarded Fast Company's Most Innovative in 2024 and PRovoke's 2024 Technology Agency of the Year, Mission North is a strategic communications agency that helps technology and life sciences companies accelerate their market impact at every growth stage. By integrating PR, digital marketing, public affairs, and data-driven influencer and content strategies, Mission North enables innovative companies to navigate the complex challenges shaping their growth and reputation. From managing conflicting stakeholder expectations on polarizing social issues to addressing the rise of AI and evolving trust in the technology ecosystem, Mission North provides the guidance needed in a rapidly shifting media landscape. The agency is headquartered in New York and San Francisco, with offices in Los Angeles, Boston, Washington D.C., and Portland, Oregon. For more information, visit www.missionnorth.com.